在克罗恩氏病和性结肠炎中具有不确定潜力的克隆性血液形成
Myvizhi Esai Selvan1, Daniel I Nathan2, Daniela Guisado3
1Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, Box 1498, New York, NY 10029, USA.
Inflammatory bowel diseases
|January 6, 2025
概括
不确定潜力的克隆性血液形成 (CHIP) 与炎症性肠病 (IBD) 有关. 在IBD患者中,CHIP具有独特的风险,特别是老年性结肠炎和年轻克罗恩病患者,需要临床意识.
科学领域:
- 血液学 血液学 血液学
- 胃肠病学 胃肠病学
- 遗传学 是一个遗传学.
背景情况:
- 不确定潜力的克隆性血液形成 (CHIP) 涉及血液细胞的体质突变,没有恶性病变.
- 炎症是CHIP进展到血液恶性瘤的可疑驱动因素.
- CHIP患者经常患有炎症性疾病,这促使该研究在炎症性肠病 (IBD) 中进行.
研究的目的:
- 确定IBD患者中CHIP的患病率和特征.
- 研究CHIP和IBD亚型 (克罗恩病和性结肠炎) 之间的关系.
主要方法:
- 分析了来自587名克罗恩病患者,441名性结肠炎患者和293名非IBD对照患者的全外测序数据.
- 用于评估CHIP流行率和与临床结果的关联的后勤回归.
主要成果:
- 较年长的性结肠炎患者 (>45) 呈现出更多的髓状CHIP突变 (P=.01).
- 淋巴状CHIP在老年IBD患者中更常见 (P=.007).
- 年轻的克罗恩病患者有高风险的骨髓状-CHIP. 类固醇使用与CHIP增加相关 (P=.05),而抗TNF治疗降低了髓质CHIP (P=.03). 路径分析显示CHIP基因,IBD和炎症之间的重叠.
结论:
- 在IBD和CHIP病理生理学之间存在着重要的联系.
- 患有CHIP的IBD患者表现出不同的风险概况,特别是老年UC和年轻CD患者.
- 这些发现表明IBD中CHIP独特的进化途径,需要提供者对恶性瘤和心血管疾病等潜在并发症的认识.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Inflammatory Bowel Disease II: Crohn's Disease
183
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
183
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Inflammatory Bowel Disease I: Ulcerative Colitis
135
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
135
Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K


